D46.9
Myelodysplastic syndrome, unspecified
Clinical Classification Guidelines
Inclusion Terms
- Myelodysplasia NOS
Medical Intelligence & Overview
Myelodysplastic syndrome (MDS) is a group of disorders caused by poorly formed or dysfunctional blood cells, which originate in the bone marrow. It's often called a 'bone marrow failure disorder' because it impacts the production of healthy blood cells. MDS can vary in severity, with some cases progressing slowly and others advancing more rapidly. The exact cause of MDS is often unknown, making diagnosis and management challenging, but early identification can help in managing symptoms and improving quality of life.
Causes & Symptoms
Clinical Causes: Previous exposure to chemotherapy or radiation therapy Prolonged exposure to environmental toxins like benzene Inherited genetic conditions Older age, as the risk increases with age Certain blood disorders or previous bone marrow problems
Key Symptoms: Fatigue and weakness Increased frequency of infections Easy bruising or bleeding Pale skin due to anemia Shortness of breath Fever without an apparent infection Unusual bleeding from gums or nose Unexplained weight loss
Diagnostic & Treatment
Diagnosis Path: Diagnosis of MDS involves a combination of blood tests, bone marrow biopsies, and genetic studies. Blood tests may show abnormal levels of blood cells, such as low red blood cells, white blood cells, or platelets. A bone marrow biopsy provides a detailed view of cell production and helps confirm the diagnosis. Additional genetic testing assists in determining the specific type of MDS and guides treatment options. Because the symptoms can mimic other blood disorders, thorough testing is necessary for an accurate diagnosis.
Treatment Protocols: Supportive care like blood transfusions to manage anemia and prevent bleeding Medications such as growth factors to stimulate blood cell production Chemotherapy to reduce abnormal cell growth Disease-modifying drugs like hypomethylating agents Stem cell or bone marrow transplants in eligible patients Clinical trials exploring new therapies
Clinical Advice & FAQs
Billing Guidance
Is D46.9 a billable ICD-10 code?
Yes, D46.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D46.9?
Clinical documentation must specify the nature of Myelodysplastic syndrome, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference